Qvents

Qvents

Discussion forum for Pharma Quality events, Regulatory Actions

Warning letters, 483s, Recalls, Import Alerts, Audit observations

Temperature excursion in transport cause

Baxter initiated recall of one lot of Doxil (doxorubicin hydrochloride liposome injection) in U.S due

US Repackager Spectrum gets USFDA 483 wi

Spectrum Laboratories Inc, New Jersey, USA (FEI 2246824) was inspected by FDA investigators Sayyem H

Biocon Malaysia inspection classified OA

In a communique Biocon stated USFDA has categorised inspection classification for Biocon Malaysia as OAI

FDA Approves Pfizer’s VELSIPITY  (etr

Velsipity (etrasimod) is an oral, once-daily, 2mg dose medication for adults with moderately to severely

Biocon’s Biosimilar insulin Aspart rec

In a company announcement, Biocon informed that it has received a CR (Complete response) letter

Industry will see more unannounced inspe

In an Interview to CNBCTV18 during visit to India, USFDA Commissioner touched on different topics

FDA publishes revised MAPP document for

The Section 5200.14 of the Manual of Policies and Procedures (MAPP), Filing Review of Abbreviated

Hospira recall Injection products in US

Hospira recalled in US one lot of 4.2% Sodium bicarbonate injection and one lot each

USFDA awards $27 Million for 10 new clin

USFDA announced it has awarded 10 new clinical trial studies through Orphan Products Grants Program

WHO set to launch electronic Platform fo

The electronic platform for processing Prequalification Information of Medicines – ePQs will enable manufacturers, National